COVID-19 has reshaped the world in profound ways over the past few years, but as we progress into 2025, the focus is shifting from pandemic to endemic. This transition means that COVID-19 will likely remain a part of our lives, but in a more predictable, manageable way. Understanding how we live with COVID-19 as an endemic disease is key to mitigating its impact on public health and daily life.
Currently browsing: Future
ASSURE In the News
Learning from COVID-19 and Asymptomatic Spread
In his new book, Prof. Weitz emphasizes how COVID-19 is evolving away from the heights of the pandemic and toward a seasonal endemic disease, characterized by silent asymptomatic spread, which complicates containment.
COVID-19 Rapid Testing: What to Do if You Test Positive
At-home rapid testing makes it possible to know your infection status quickly and monitor your health over time. So What Should I Do If I Am Positive?
Is It OK to Stop Worrying about COVID?
A recent article from BU Today, Boston University’s daily news website, posed the question, is it OK to stop worrying about COVID? This shift in mindset doesn’t mean ignoring COVID-19; instead, it involves adapting our approach to fit the current reality.
The Importance of Rapid COVID-19 Testing in Routine Vaccination Strategies
The fight against COVID-19 has entered a new phase in 2024, one in which vaccinations have become “routine”, like an annual flu shot.
Predicted Seasonal Surges of COVID-19 in the Winter of 2024
Rapid testing remains our primary way to remain vigilant against new variant outbreaks and spreading of the virus during seasonal trends which hit in waves.
Rapid Testing and Stemming COVID-19 Spread During the Winter of 2024
As we enter the winter of 2024, concerns over COVID-19 transmission are heightened due to increased indoor activities, increased travel and holiday-related gatherings, and prevalence of other seasonal respiratory illnesses.
PRESS RELEASE | Oceanit Selected As a Semi-Finalist For the XPRIZE Rapid Covid Testing Competition
Oceanit’s ASSURE-19 Covid-19 test was selected as a semifinalist from a pool of nearly 700 teams from around the world competing for the XPRIZE for Rapid Covid Testing. We will now perform blind proficiency testing on inactive virus samples sent to us by the XPRIZE Foundation as the next step towards becoming a finalist for the award.
The Aloha Protocol For a Safer Reopening with ASSURE-19
As Oceanit moves ahead with in-vitro and in-vivo testing for the ASSURE-19 rapid point-of-need test kits, Hawaii is seeing high, sustained counts for new covid-19 cases each day. Check out the latest articles and coverage of ASSURE-19 from the Washington Post, Hawaii Public Radio, and Honolulu Star Advertiser.
ASSURE-19 Featured on Hawaii News Now, Honolulu Star Advertiser, and Pacific Business News
Oceanit is focusing on quickly bringing ASSURE-19 to market, organizing manufacturing so that we can provide schools, emergency responders, and airports with a simple saliva test to make high-risk situations safer. This phase of funding and work will help with regulatory compliance and approval, as well as support for accelerating a ‘go to market’ timeline and scale manufacturing.